Healthy Skepticism Library item: 12402

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Larsson DG, de Pedro C, Paxeus N.
Effluent from drug manufactures contains extremely high levels of pharmaceuticals.
J Hazard Mater 2007 Sep 30; 148:(3):751-5
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TGF-4P4FV8H-6&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=7447b86be93edc1676114c3ebcc42b0a

Abstract:

It is generally accepted that the main route for human pharmaceuticals to the aquatic environment is via sewage treatment plants receiving wastewater from households and hospitals. We have analysed pharmaceuticals in the effluent from a wastewater treatment plant serving about 90 bulk drug manufacturers in Patancheru, near Hyderabad, India—a major production site of generic drugs for the world market. The samples contained by far the highest levels of pharmaceuticals reported in any effluent. The high levels of several broad-spectrum antibiotics raise concerns about resistance development. The concentration of the most abundant drug, ciprofloxacin (up to 31,000 microg/L) exceeds levels toxic to some bacteria by over 1000-fold. The results from the present study call for an increased focus on the potential release of active pharmaceutical ingredients from production facilities in different regions.

Keywords:
Drug Industry* Drug Residues/analysis Drug Residues/chemistry* Drug Residues/toxicity Fresh Water India Industrial Waste* Sewage/chemistry* Toxicity Tests Waste Disposal, Fluid/methods Waste Disposal, Fluid/statistics & numerical data* Water Pollutants, Chemical/analysis Water Pollutants, Chemical/chemistry* Water Pollutants, Chemical/toxicity